A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 478 participants.

Also called NCT07359807

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 478 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07359807
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07359807. Randomized; double masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
Acronym
MAGICAL SFA
Condition
Popliteal Artery Disease
Condition
Superficial Femoral Artery Disease
Intervention (Combination product)
Sirolimus (RAPAMUNE) drug-coated balloon angioplasty catheter
Intervention (Combination product)
Paclitaxel drug-coated balloon angioplasty
Lead sponsor
Concept Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct07359807
Content hash
89d1b324630a808c4155a987021cc1b1ec781a246ff0fc49b8f4a3a6e4432c80